GEA opens factory in India

Published: 23-Mar-2010
Manufacturing

Vadodara, Gujarat factory provides local build of processing equipment

GEA Pharma Systems has opened a new factory in Vadodara, Gujarat to service India and provide reduced-cost manufacturing of high-technology solid dose and liquid pharmaceutical processing equipment for the local market. The company will initially manufacture fluid bed and granulation technology in the new facility and will extend the scope of production to meet growing demand.

Until now GEA Pharma Systems, the technology leader in pharmaceutical processing, has manufactured outside India, mainly in Europe. The new factory will offer strategic low-cost manufacturing, allowing the company to provide European-quality processing equipment at prices that are affordable in the growing Indian market.

‘India is a high-growth market that’s very price-sensitive and susceptible to technology,’ said Navin Lakhanpaul, regional manager for GEA Pharma Systems in Vadodara. ‘This low-cost manufacturing base will allow us to provide the high-end, European quality products our Indian customers need at prices that are appropriate to the local market.’ He added that the local manufacture will also help the company be more reactive to local market demands.

The factory will employ local staff and peripheral equipment, such as control systems, will also be sourced locally, providing an additional boost to local suppliers. ‘In most projects, much of the project value is in peripheral equipment. It’s also essential for us to keep the technical know-how close at hand to help us maintain the efficient after-sales service our customers expect,’ said Navin.

The effects of low-cost manufacturing, locally-sourced peripheral equipment and reduced transportation costs can often reduce the equipment price significantly when compared with equipment bought from Europe.

Navin also explained that the high quality approach satisfied the demand for all pharmaceutical equipment produced in India to meet international quality standards. ‘Not only do our Indian customers want to supply the local market with high-quality products they also want the facilities necessary to sell into Europe and offer manufacturing services to European customers. Our equipment provides the necessary quality, efficiency and environmental control to allow them to do so.’

Frans Maas, GEA Pharma Systems’ division director for sales and marketing, commented that the new facility was critical to the organisation’s long-term plans. ‘The factory in Vadodora is an important development for our company and part of our strategy for sustainable supply,’ he explained. The opening of the factory, for example, follows soon after GEA’s announcement of two agency agreements with ACE Technologies of Mumbai, for the distribution of MODUL tablet presses from GEA Courtoy and pharmaceutical freeze drying technology from GEA Lyophil throughout India.

The factory has been built adjacent to the company’s existing office building which was opened in 2007.
See more

You may also like

Manufacturing

BD and Suttons Creek collaborate to streamline combination product development for pharma and biotech

Read more
The new strategic collaboration will help pharmaceutical and biotech companies reduce development risk and regulatory complexity across drug-device combination products, including biologics and GLP-1 therapies

Trending Articles

  1. FDA issues first cGMP warning letter citing AI misuse in pharmaceutical manufacturing A Michigan-based lab has become the subject of the FDA's first dedicated enforcement action on artificial intelligence misuse in drug manufacturing — a landmark event with far-reaching implications for cGMP compliance across the pharmaceutical supply chain
  2. Freudenberg Medical launches CleanAssure ISO Class 5 cleanroom service for sterile single-use biopharma assemblies CleanAssure is an ISO Class 5 controlled cleanroom service delivering washed, dried and gamma-sterilised single-use assemblies to biopharmaceutical customers, addressing industry challenges around cleaning validation and contamination risk
  3. First aid readiness in analytical laboratories Preparing for chemical emergencies with specialist equipment and training
  4. Romaco Holding GmbH Romaco is a leading international supplier of machinery and integrated system solutions for the development, production and packaging of pharmaceuticals, nutraceuticals, food, cosmetic and chemical products. All from a single source.
  5. Japanese pharma companies shifting to earlier CDMO outsourcing as peptide complexity increases Neuland Laboratories has reported a notable shift in Japanese pharmaceutical outsourcing patterns during the past 12-24 months, with companies engaging CDMOs earlier in the development cycle

Upcoming event

CHEMUK 2026

20–21 May 2026 | Conference and Exhibition | Birmingham, UK See all

You may also like

Manufacturing

BD and Suttons Creek collaborate to streamline combination product development for pharma and biotech

The new strategic collaboration will help pharmaceutical and biotech companies reduce development risk and regulatory complexity across drug-device combination products, including biologics and GLP-1 therapies
Manufacturing

Miltenyi Biotec and CHA Biotech collaborate on BaEV lentiviral vector platform

The pair will work to enhance CAR NK cell therapy manufacturing efficiency, combining Miltenyi Bioindustry's baboon envelope lentiviral vector platform with CHA Biotech's NK cell research expertise to improve gene delivery, scalability and cost of goods
Manufacturing

Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services collaborate to support ADC development and manufacturing

Piramal and Ajinomoto Bio-Pharma Services have entered a collaborative arrangement aimed at enhancing their customers’ ADC development and manufacturing programs
Manufacturing

Cipla receives FDA approval for first AB-rated generic of Ventolin HFA in $1.5bn US albuterol market

Indian pharmaceutical company Cipla has secured final FDA approval for its Albuterol Sulfate Inhalation Aerosol, becoming the first AB-rated generic therapeutic equivalent of GlaxoSmithKline's Ventolin HFA
Manufacturing

Japanese pharma companies shifting to earlier CDMO outsourcing as peptide complexity increases

Neuland Laboratories has reported a notable shift in Japanese pharmaceutical outsourcing patterns during the past 12-24 months, with companies engaging CDMOs earlier in the development cycle
Manufacturing

FDA issues first cGMP warning letter citing AI misuse in pharmaceutical manufacturing

A Michigan-based lab has become the subject of the FDA's first dedicated enforcement action on artificial intelligence misuse in drug manufacturing — a landmark event with far-reaching implications for cGMP compliance across the pharmaceutical supply chain
Manufacturing

Precision meets innovation in melting point determination

Advancing analytical accuracy with automated thermal analysis
Subscribe now